CD47 overexpression in HRS cells is frequent and there are no significant differences between cHL patients with high and low expression respect to the clinical stage, histological subtype sex, EBV status or the presence of B symptoms. The gene discussed is CD47; the disease is classic Hodgkin lymphoma.